Today, the Company manufactures and markets API (Bulk Actives), Finished Dosages to over 100 companies worldwide, in addition to having a very promising Drug Pipeline. Sangrose continues its journey leveraging on its ‘Low Cost, High Intellect’ advantage foraying into new markets and new businesses. Taking on new challenges and growing stronger and more capable.

Our specialty product range features solid oral dosage forms (tablets, capsules-hard gelatine and soft gelatine), Creams, ointments and liquid orals.